Biosolution Co (XKRX:086820) Total Stockholders Equity : ₩29,037 Mil (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Biosolution Co Total Stockholders Equity?

Biosolution Co's Total Stockholders Equity for the quarter that ended in Mar. 2025 was ₩29,037 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Biosolution Co's Book Value per Share for the quarter that ended in Mar. 2025 was ₩1,206.30. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Biosolution Co's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.99.

Biosolution Co Total Stockholders Equity Historical Data

The historical data trend for Biosolution Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosolution Co Total Stockholders Equity Chart

Biosolution Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

46,664.21

45,012.97

43,775.10

42,129.64

31,257.45

Biosolution Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															38,767.02	39,936.50	36,315.54	31,257.45	29,036.76

Biosolution Co (XKRX:086820) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Biosolution Co's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(29036.764	-	0)	/	24.071
	=	1,206.30

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Biosolution Co's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(27933.937	+	727.002)	/	29036.764
	=	0.99

Biosolution Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Biosolution Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosolution Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosolution Co Ltd (XKRX:086820) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Gongneung-Ro 232, Nowon-gu, 5th Floor, Room 519, Seoul Technopark, Seoul, KOR

Website

http://www.biosolutions.co.kr

Biosolution Co Ltd is a Korean company offering Cell-Based Biotechnology. It is engaged in manufacturing and selling cell therapy products, and developing cell therapeutics technology. Its main areas include cell-based therapeutics with their background in somatic and stem cell technology, and the manufacturing, sales, and R&D of human tissue models for screening toxicity and efficacy with tissue engineering technology.

Biosolution Co Headlines

No Headlines